Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Sempra has a consensus price target of $94.74 based on the ratings of 19 analysts. The high is $167 issued by Goldman Sachs on July 6, 2022. The low is $70 issued by Citigroup on April 9, 2025. The 3 most-recent analyst ratings were released by BMO Capital, Jefferies, and Citigroup on May 12, 2025, April 15, 2025, and April 9, 2025, respectively. With an average price target of $75.33 between BMO Capital, Jefferies, and Citigroup, there's an implied -3.03% downside for Sempra from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/12/2025 | Buy Now | 4.26% | BMO Capital | James Thalacker76% | $78 → $81 | Maintains | Outperform | Get Alert |
04/15/2025 | Buy Now | -3.46% | Jefferies | Julien Dumoulin-Smith68% | $77 → $75 | Maintains | Hold | Get Alert |
04/09/2025 | Buy Now | -9.9% | Citigroup | Ryan Levine69% | $93 → $70 | Maintains | Neutral | Get Alert |
03/26/2025 | Buy Now | 9.41% | Wells Fargo | Sarah Akers68% | $88 → $85 | Maintains | Overweight | Get Alert |
03/20/2025 | Buy Now | 10.7% | Morgan Stanley | David Arcaro68% | $85 → $86 | Maintains | Overweight | Get Alert |
03/04/2025 | Buy Now | 0.4% | BMO Capital | James Thalacker76% | $92 → $78 | Maintains | Outperform | Get Alert |
03/03/2025 | Buy Now | -0.89% | Jefferies | Julien Dumoulin-Smith68% | $96 → $77 | Downgrade | Buy → Hold | Get Alert |
02/27/2025 | Buy Now | -7.32% | Barclays | Nicholas Campanella65% | $95 → $72 | Downgrade | Overweight → Equal-Weight | Get Alert |
02/26/2025 | Buy Now | -2.18% | Goldman Sachs | Carly Davenport50% | $99 → $76 | Downgrade | Buy → Neutral | Get Alert |
02/26/2025 | Buy Now | -2.18% | Mizuho | Anthony Crowdell64% | $92 → $76 | Maintains | Outperform | Get Alert |
02/26/2025 | Buy Now | 11.98% | Guggenheim | Shahriar Pourreza68% | $95 → $87 | Maintains | Buy | Get Alert |
02/26/2025 | Buy Now | 9.41% | Morgan Stanley | David Arcaro68% | $100 → $85 | Maintains | Overweight | Get Alert |
02/26/2025 | Buy Now | 0.4% | UBS | Daniel Ford70% | $95 → $78 | Downgrade | Buy → Neutral | Get Alert |
02/26/2025 | Buy Now | 13.27% | Wells Fargo | Sarah Akers68% | $96 → $88 | Maintains | Overweight | Get Alert |
01/27/2025 | Buy Now | 22.28% | Barclays | Eric Beaumont70% | $99 → $95 | Maintains | Overweight | Get Alert |
12/13/2024 | Buy Now | 26.14% | Morgan Stanley | David Arcaro68% | $85 → $98 | Upgrade | Equal-Weight → Overweight | Get Alert |
12/02/2024 | Buy Now | 27.43% | Barclays | Eric Beaumont70% | $89 → $99 | Maintains | Overweight | Get Alert |
11/07/2024 | Buy Now | 23.57% | Wells Fargo | Sarah Akers68% | $87 → $96 | Maintains | Overweight | Get Alert |
11/07/2024 | Buy Now | 13.27% | Evercore ISI Group | Durgesh Chopra66% | $84 → $88 | Maintains | Outperform | Get Alert |
10/24/2024 | Buy Now | 26.14% | Jefferies | Julien Dumoulin-Smith68% | → $98 | Initiates | → Buy | Get Alert |
10/21/2024 | Buy Now | 23.57% | BMO Capital | James Thalacker76% | $93 → $96 | Maintains | Outperform | Get Alert |
10/01/2024 | Buy Now | 14.56% | Barclays | Eric Beaumont70% | $87 → $89 | Maintains | Overweight | Get Alert |
09/25/2024 | Buy Now | 9.41% | Morgan Stanley | David Arcaro68% | $80 → $85 | Maintains | Equal-Weight | Get Alert |
09/12/2024 | Buy Now | 20.99% | B of A Securities | Ross Fowler62% | → $94 | Reinstates | → Buy | Get Alert |
09/12/2024 | Buy Now | 19.71% | BMO Capital | James Thalacker76% | $90 → $93 | Maintains | Outperform | Get Alert |
08/23/2024 | Buy Now | 2.97% | Morgan Stanley | David Arcaro68% | $77 → $80 | Maintains | Equal-Weight | Get Alert |
08/13/2024 | Buy Now | 11.98% | Barclays | Eric Beaumont70% | $81 → $87 | Maintains | Overweight | Get Alert |
08/07/2024 | Buy Now | 8.12% | Evercore ISI Group | Durgesh Chopra66% | $83 → $84 | Maintains | Outperform | Get Alert |
07/10/2024 | Buy Now | 8.12% | BMO Capital | James Thalacker76% | $86 → $84 | Maintains | Outperform | Get Alert |
06/24/2024 | Buy Now | -2.18% | Morgan Stanley | David Arcaro68% | $79 → $76 | Maintains | Equal-Weight | Get Alert |
05/29/2024 | Buy Now | 1.69% | Ladenburg Thalmann | Paul Fremont62% | $81.5 → $79 | Maintains | Buy | Get Alert |
05/17/2024 | Buy Now | 10.7% | Mizuho | Anthony Crowdell64% | $79 → $86 | Maintains | Buy | Get Alert |
05/08/2024 | Buy Now | 8.12% | Wells Fargo | Sarah Akers68% | $79 → $84 | Maintains | Overweight | Get Alert |
03/21/2024 | Buy Now | -3.46% | Morgan Stanley | David Arcaro68% | $74 → $75 | Maintains | Equal-Weight | Get Alert |
03/14/2024 | Buy Now | 1.69% | Barclays | Eric Beaumont70% | $77 → $79 | Maintains | Overweight | Get Alert |
03/06/2024 | Buy Now | 5.55% | RBC Capital | Shelby Tucker66% | $82 → $82 | Reiterates | Outperform → Outperform | Get Alert |
01/25/2024 | Buy Now | 1.69% | Mizuho | Anthony Crowdell64% | $83 → $79 | Maintains | Buy | Get Alert |
01/22/2024 | Buy Now | -0.89% | Barclays | Eric Beaumont70% | $76 → $77 | Maintains | Overweight | Get Alert |
01/11/2024 | Buy Now | 8.12% | BMO Capital | James Thalacker76% | $76 → $84 | Upgrade | Market Perform → Outperform | Get Alert |
01/03/2024 | Buy Now | 4.9% | Ladenburg Thalmann | Paul Fremont62% | → $81.5 | Initiates | → Buy | Get Alert |
12/12/2023 | Buy Now | 10.7% | JP Morgan | Christopher Turnure65% | $78 → $86 | Upgrade | Neutral → Overweight | Get Alert |
11/21/2023 | Buy Now | -6.04% | Morgan Stanley | David Arcaro68% | $75 → $73 | Maintains | Equal-Weight | Get Alert |
10/25/2023 | Buy Now | -3.46% | Morgan Stanley | David Arcaro68% | $78 → $75 | Maintains | Equal-Weight | Get Alert |
10/24/2023 | Buy Now | -2.18% | Barclays | Eric Beaumont70% | $78 → $76 | Maintains | Overweight | Get Alert |
10/17/2023 | Buy Now | 0.4% | JP Morgan | Christopher Turnure65% | $82 → $78 | Maintains | Neutral | Get Alert |
10/04/2023 | Buy Now | 14.56% | UBS | Daniel Ford70% | $95 → $89 | Maintains | Buy | Get Alert |
09/21/2023 | Buy Now | 0.4% | Morgan Stanley | David Arcaro68% | $76 → $78 | Maintains | Equal-Weight | Get Alert |
09/06/2023 | Buy Now | 5.55% | RBC Capital | Shelby Tucker66% | $91 → $82 | Maintains | Outperform | Get Alert |
08/23/2023 | Buy Now | -2.18% | Morgan Stanley | David Arcaro68% | $79 → $76 | Maintains | Equal-Weight | Get Alert |
08/23/2023 | Buy Now | 100.8% | Barclays | Eric Beaumont70% | → $156 | Initiates | → Overweight | Get Alert |
08/07/2023 | Buy Now | 105.95% | BMO Capital | James Thalacker76% | $168 → $160 | Maintains | Market Perform | Get Alert |
08/04/2023 | Buy Now | 113.67% | Wells Fargo | Sarah Akers68% | $174 → $166 | Maintains | Overweight | Get Alert |
07/21/2023 | Buy Now | 103.37% | Morgan Stanley | David Arcaro68% | $158 → $158 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/11/2023 | Buy Now | 121.39% | Guggenheim | Shahriar Pourreza68% | → $172 | Reiterates | Buy → Buy | Get Alert |
07/07/2023 | Buy Now | 121.39% | Guggenheim | Shahriar Pourreza68% | $174 → $172 | Maintains | Buy | Get Alert |
06/23/2023 | Buy Now | 103.37% | Morgan Stanley | David Arcaro68% | $163 → $158 | Maintains | Equal-Weight | Get Alert |
06/08/2023 | Buy Now | 129.12% | Goldman Sachs | Carly Davenport50% | → $178 | Initiates | → Buy | Get Alert |
05/22/2023 | Buy Now | 109.81% | Morgan Stanley | David Arcaro68% | $164 → $163 | Maintains | Equal-Weight | Get Alert |
04/20/2023 | Buy Now | 111.1% | Morgan Stanley | David Arcaro68% | $150 → $164 | Maintains | Equal-Weight | Get Alert |
03/28/2023 | Buy Now | 112.38% | B of A Securities | Julien Dumoulin-Smith68% | $173 → $165 | Maintains | Buy | Get Alert |
03/21/2023 | Buy Now | 93.08% | Morgan Stanley | David Arcaro68% | $158 → $150 | Maintains | Equal-Weight | Get Alert |
03/01/2023 | Buy Now | 123.97% | Wells Fargo | Sarah Akers68% | $180 → $174 | Maintains | Overweight | Get Alert |
03/01/2023 | Buy Now | 113.67% | BMO Capital | James Thalacker76% | $169 → $166 | Maintains | Market Perform | Get Alert |
02/22/2023 | Buy Now | 103.37% | Morgan Stanley | Stephen Byrd49% | $160 → $158 | Maintains | Equal-Weight | Get Alert |
01/23/2023 | Buy Now | 105.95% | Morgan Stanley | Stephen Byrd49% | $162 → $160 | Maintains | Equal-Weight | Get Alert |
12/15/2022 | Buy Now | 108.52% | Morgan Stanley | Stephen Byrd49% | $153 → $162 | Maintains | Equal-Weight | Get Alert |
12/14/2022 | Buy Now | 131.69% | Wells Fargo | Sarah Akers68% | $168 → $180 | Maintains | Overweight | Get Alert |
11/11/2022 | Buy Now | 96.94% | Morgan Stanley | Stephen Byrd49% | $144 → $153 | Maintains | Equal-Weight | Get Alert |
10/21/2022 | Buy Now | 85.35% | Morgan Stanley | Stephen Byrd49% | $165 → $144 | Maintains | Equal-Weight | Get Alert |
10/19/2022 | Buy Now | 116.24% | Wells Fargo | Sarah Akers68% | $189 → $168 | Maintains | Overweight | Get Alert |
10/03/2022 | Buy Now | 107.23% | Mizuho | Anthony Crowdell64% | $173 → $161 | Maintains | Buy | Get Alert |
09/22/2022 | Buy Now | 112.38% | Morgan Stanley | Stephen Byrd49% | $169 → $165 | Maintains | Equal-Weight | Get Alert |
09/15/2022 | Buy Now | 143.27% | Wells Fargo | Sarah Akers68% | $184 → $189 | Maintains | Overweight | Get Alert |
08/23/2022 | Buy Now | 117.53% | Morgan Stanley | Stephen Byrd49% | $160 → $169 | Maintains | Equal-Weight | Get Alert |
07/21/2022 | Buy Now | 105.95% | Morgan Stanley | Stephen Byrd49% | $152 → $160 | Maintains | Equal-Weight | Get Alert |
07/18/2022 | Buy Now | 126.54% | Barclays | Eric Beaumont70% | $186 → $176 | Maintains | Overweight | Get Alert |
07/14/2022 | Buy Now | — | B of A Securities | Julien Dumoulin-Smith68% | — | Upgrade | Neutral → Buy | Get Alert |
07/06/2022 | Buy Now | 114.96% | Goldman Sachs | Michael Lapides60% | $164 → $167 | Upgrade | Neutral → Buy | Get Alert |
The latest price target for Sempra (NYSE:SRE) was reported by BMO Capital on May 12, 2025. The analyst firm set a price target for $81.00 expecting SRE to rise to within 12 months (a possible 4.26% upside). 31 analyst firms have reported ratings in the last year.
The latest analyst rating for Sempra (NYSE:SRE) was provided by BMO Capital, and Sempra maintained their outperform rating.
The last upgrade for Sempra happened on December 13, 2024 when Morgan Stanley raised their price target to $98. Morgan Stanley previously had an equal-weight for Sempra.
The last downgrade for Sempra happened on March 3, 2025 when Jefferies changed their price target from $96 to $77 for Sempra.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sempra, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sempra was filed on May 12, 2025 so you should expect the next rating to be made available sometime around May 12, 2026.
While ratings are subjective and will change, the latest Sempra (SRE) rating was a maintained with a price target of $78.00 to $81.00. The current price Sempra (SRE) is trading at is $77.69, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.